Is Citius Pharmaceuticals Inc (CTXR) a Winner in the Biotechnology Industry?

The 49 rating InvestorsObserver gives to Citius Pharmaceuticals Inc (CTXR) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 72 percent of stocks in the Biotechnology industry, CTXR’s 49 overall rating means the stock scores better than 49 percent of all stocks.

CTXR has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on CTXR!

See Full CTXR Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 49 means the stock is more attractive than 49 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Citius Pharmaceuticals Inc Stock Today?

Citius Pharmaceuticals Inc (CTXR) stock is trading at $2.04 as of 10:19 AM on Tuesday, Oct 5, a gain of $0.09, or 4.36% from the previous closing price of $1.95. The stock has traded between $1.96 and $2.04 so far today. Volume today is below average. So far 356,588 shares have traded compared to average volume of 3,018,662 shares. Click Here to get the full Stock Report for Citius Pharmaceuticals Inc stock.